The grant will help diversify research methods to increase the likelihood of a successful treatment for the degenerative progressive disease that affects 1 in every 40,000 people worldwide and currently has limited treatment options.
This is the 70th year of partnership between IAFF and MDA raising over $700 million in funds to advance care and accelerate research for MDA families living with muscular dystrophy, ALS, and related neuromuscular diseases.